Quest HealthConnect(TM): Personalized Access to Quality Healthcare

08 May 2023
www.biospace.com
NORTHAMPTON, MA / ACCESSWIRE / May 8, 2023 / Quest Diagnostics: Quest HealthConnect™ is dedicated to increasing access to quality extended care services that: Enable health plans and clinical providers to more effectively assess vulnerable patients and close critical gaps in care Help to increase access to quality healthcare by delivering individualized care options that connect patients where they are-whether at home, in a local Quest patient service center, or another convenient setting Improve satisfaction among members of healthcare plans, particularly those enrolled in Medicare and managed Medicaid Facilitate early detection of chronic and acute illness Enhance member education and their ability to take full advantage of their benefits Improve overall quality of care Enabled by a national network of trusted, long-standing relationships with medical professionals, Quest HealthConnect provides a personalized approach, often at members' homes, through an on-site Health Risk Assessment (HRA). HRAs factor in crucial social determinants of health combinations-including housing and transportation, psychosocial factors, access to nutritious food, financial barriers, and access to community services and resources-to help members understand their health risks and take steps to improve their overall health. Health plans use data obtained from the HRAs to: Coordinate care with physicians who can guide patients in taking appropriate preventive care measures to reduce identified health risks Help members get ahead of common chronic medical conditions, including cardiovascular disease (CVD), diabetes, and kidney disease In addition to HRAs, Quest HealthConnect offers additional services, including screenings for diabetic retinopathy, diabetes, osteoporosis, and colorectal cancer Read more View additional multimedia and more ESG storytelling from Quest Diagnostics on 3blmedia.com. Contact Info: Spokesperson: Quest Diagnostics Website: Email: info@3blmedia.com SOURCE: Quest Diagnostics View source version on accesswire.com:
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.